Four (4) each Genomic Sequencing Systems
| Location: | Federal |
|---|---|
| Posted: | Jun 15, 2026 |
| Due: | Jun 26, 2026 |
| Agency: | HEALTH AND HUMAN SERVICES, DEPARTMENT OF |
| Type of Government: | Federal |
| Category: |
|
| Solicitation No: | RFQ-FDA-133845-133915 |
| Publication URL: | To access bid details, please log in. |
APEX Accelerators are an official government contracting resource for small businesses. Find your local APEX Accelerator (opens in new window) for free government expertise related to contract opportunities.
APEX Accelerators are funded in part through a cooperative agreement with the Department of Defense.
The APEX Accelerators program was formerly known as the Procurement Technical Assistance Program (opens in new window) (PTAP).
- Contract Opportunity Type: Combined Synopsis/Solicitation (Original)
- Original Published Date: Jun 15, 2026 05:03 pm EDT
- Original Date Offers Due: Jun 26, 2026 10:00 am EDT
- Inactive Policy: Manual
- Original Inactive Date: Jun 27, 2026
-
Initiative:
- None
- Original Set Aside: No Set aside used
- Product Service Code: 6640 - LABORATORY EQUIPMENT AND SUPPLIES
-
NAICS Code:
- 334516 - Analytical Laboratory Instrument Manufacturing
-
Place of Performance:
USA
This acquisition is restricted to brand name or equal: Illumina MiSeq i100 Plus and Illumina DRAGENTM Bio-IT Platform because these systems will replace aging sequencers currently owned by the FDA. FDA needs continuity of maintaining the same sequencing methods, proprietary flow cells and reagents or equal, software licenses, and manufacturer-supported components necessary to operate mission driven project continuity.
1. Purpose
The purpose of this procurement is to acquire four (4) Illumina MiSeq i100 Plus desktop genomic sequencing systems to support the FDA’s Human Foods Program (HFP). These systems will replace aging sequencers currently in use and enable high-throughput, cost-effective, and rapid sequencing critical for food safety surveillance, regulatory compliance, and the development of novel genomic applications. The acquisition directly supports FDA's mission to enhance public health through timely detection and characterization of foodborne pathogens in regulated products.
- 11601 Landsdown St Floor 13
- Rockville , MD 20852
- USA
- Sarah Hussain
- Sarah.Hussain@fda.hhs.gov
- Jun 15, 2026 05:03 pm EDTCombined Synopsis/Solicitation (Original)
Related Document
| Jun 23, 2026 | [Combined Synopsis/Solicitation (Updated)] Four (4) each Genomic Sequencing Systems |
With GovernmentContracts, you can:
- Find more opportunities and win more business
- Receive daily alerts for all new bid opportunities
- Get contract opportunities matched to your business